Searched for
DRUGS FACTORY IN UK
School assembly news headlines for June 16: Top national, international, business, sports update and thought of the dayIndia and Slovakia elevate ties to a comprehensive partnership. A rival tutor accuses Khan Sir of murder. Delhi census Phase 1 records over...- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
- Trump eyes fresh tariff probe focused on foreign drug pricesPresident Trump is initiating a new investigation into drug prices, aiming to compel foreign nations to pay the same as Americans for their...
- India's drug regulator to streamline export process to reduce workloadIndia's drug regulator plans reforms to ease export clearances and simplify manufacturing licenses to reduce workforce strain. With only 2,...
- Three Indian-origin men jailed in UK for running large-scale drugs factoryIndian-origin men, including a father-son duo, have been sentenced to a total of 24 years imprisonment after being convicted of running wha...
- Supplements have no health benefits, eat real food: Top UK scientistDitch those health supplements as they have no health benefits, and are simply a money-making scheme by drug companies, according to a top ...
- EU audits Serum Institute as AstraZeneca looks to boost supplies to the bloc: SourceSII, the world's largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor a...
- The week that was in 10 stocks: NBCC, Voda, IndusInd and othersBanks and construction companies were at the forefront of the rally this week.
- Coronavirus outbreak: Your paracetamol supply depends a lot on ChinaIndia spooked the world this week by announcing curbs on exports of common drugs including paracetamol.
- World's first 'molecular robot' may help build new drugsThe tiny robots developed by researchers at the University of Manchester in the UK can be programmed to move and build molecular cargo usin...
- Andrew Witty leaves GSK with new challenges, robust pipelineThe next wave of drug launches from an active pipeline of 25 clinical programmes will determine how strongly GSK charts its future growth.
- Nestle India falls as FSSAI trashes all-clear reports to Maggi from Goa, Mysore labsNestle India fell over 5% in intraday trade on Thursday, after FSSAI said that it has not given clean chit to Maggi noodles.
- FSSAI trashes all-clear reports to Maggi from Goa, Mysore labsFSSAI said it has not given any clean chit to Nestle's banned Maggi noodles as it rubbished all-clear reports from two of its own empanelle...
- Pfizer pledges to ringfence drug development in AstraZeneca dealAstraZeneca said on Tuesday that Pfizer's proposal risked disrupting its research and delaying getting life-saving new drugs to market.
- Wockhardt in trouble after USFDA issues warning letter, missive accuses co of obstructing inspectionDrug regulator has issued a warning letter to pharma co accusing it of obstructing its team from inspecting.
- Congress MP B S Gnanadesikan demands surveillance of NGOs receiving foreign fundsA demand was raised in RS that Govt should put in place a strong surveillance network to monitor inflow of foreign funds to NGOs.
- Stocks to watch:Mukand, Tata Steel, RIL, RNRL, RanbaxyMukand, jointly controlled by the Bajaj and Shah families, is close to selling a part of its land at Kalwa near Thane for about Rs 600 cror...
- Stocks to watch: Reliance MediaWorks, Dr Reddy’s Labs, Spicejet, Radico Khaitan, Shree Cement, Parenteral Drugs, Satyam Computers: Reliance MediaWorks (RMW), which is locked in a takeover battle for multiplex operator Fame with rival Inox, has challenged the sale of m...
- Disappointing debut for Bafna Pharma; dips below issue priceDrug maker Bafna Pharmaceuticals today made a disappointing debut on the Bombay Stock Exchange and settled below its issue price at Rs 38.5...
- Nicholas Piramal undecided on strategic partner in R&D companyPharma company Nicholas Piramal to decide on partner for its new entity to be demerged from itd R&D segment.
Load More
